---
schema_version: "secwatch.filing_event.v1"
accession: "0001764046-26-000117"
form_type: "8-K"
ticker: "CLVT"
cik: "0001764046"
company_name: "CLARIVATE PLC"
filed_at: "2026-10-06T20:29:39+00:00"
generated_at: "2026-10-12T16:14:54.289873+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Clarivate closes $600M sale of Life Sciences & Healthcare to Altaris; segment head Levy departs

## Summary
- Deal consideration: $500M cash at closing plus a $75M unsecured senior note from an Altaris affiliate and $25M deferred cash payable by January 31, 2028.
- Henry Levy, President, Life Sciences & Healthcare, terminated employment at closing; separation agreement follows the retention agreement disclosed July 6, 2026.
- Clarivate will use proceeds to reduce debt; remaining portfolio is Academia & Government (Web of Science, ProQuest, Alma, Vega) and Intellectual Property (IPOne, Derwent, CompuMark, IPfolio).
- Q3 2026 results are set for November 3, 2026, when Clarivate will update full-year 2026 guidance to reflect the divestiture.
- Pro forma condensed balance sheet as of June 30, 2026 and statements of operations for 2023-2025 and 1H26 to be filed by October 13, 2026.

## SEC filing metadata
- accession: 0001764046-26-000117
- form_type: 8-K
- ticker: CLVT
- cik: 0001764046
- company_name: CLARIVATE PLC
- filed_at: 2026-10-06T20:29:39+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.01, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764046/000176404626000117/0001764046-26-000117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764046/000176404626000117/clvt-20261006.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001764046-26-000117
- JSON: https://secwatch.observer/filing/0001764046-26-000117.json
- Plain text: https://secwatch.observer/filing/0001764046-26-000117.txt

## Key facts
- Executive change
  Henry Levy departed as President, Life Sciences & Healthcare at CLARIVATE PLC.
  - Action: terminated employment
  - Role: President, Life Sciences & Healthcare
  source text: Upon the Closing and in connection with the Transaction, Henry Levy, Clarivate’s President, Life Sciences & Healthcare, terminated employment with a subsidiary of Clarivate.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1764046/000176404626000117/0001764046-26-000117-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.